Anticorpos monoclonais | sciencenewsnet.in

Breaking News

No ‘one size fits all’ treatment for Type 1 Diabetes, study finds

Chula Lecturer Wins Creative Excellence Award 2024 for “Decorative Toys for the Elderly”

Improved Spin and Density Correlation Simulations Give Researchers Clearer Insights on Neutron Stars

American Thyroid Association® Recognizes 2024 Van Meter Award Winner

Breakthrough in Hazardous Gas Detection: New Technology Enhances Miniaturization and Accuracy

Shells, teeth and bones of ‘weird and wonderful organisms’ provide historical environmental clues

Forestry Research Indexed in PubMed Central

Technology in Horticulture Successfully Indexed in Web of Science: Emerging Sources Citation Index (ESCI)

Delay and Pay: Tipping Point Costs Quadruple After Waiting

Amazon’s Return-to-Office Strategy: Expert Insights on Remote Work Challenges

27 Nov, 2024

Tratamento combinado de anticorpos monoclonais reduz hospitalização em pacientes de alto risco com COVID-19

September 7, 2021 sarah JonasResearch Results

Em um estudo observacional, pesquisadores da Mayo Clinic relatam que a combinação de casirivimabe e imdevimabe quando infectados com COVID-19 leve ou moderada. Essas conclusões foram publicadas na revista médica EClinicalMedicine da The Lancet.